These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7524508)

  • 1. Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases.
    de la Mata J; Gomez-Sanchez MA; Aranzana M; Gomez-Reino JJ
    Arthritis Rheum; 1994 Oct; 37(10):1528-33. PubMed ID: 7524508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].
    Tian Z; Chen TB; Fang Q; Zeng XF; Liu YT; Li MT; Jiang XC; Gao P; Cheng KA; Wang Q
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2099-102. PubMed ID: 20058611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group.
    Olschewski H; Ghofrani HA; Schmehl T; Winkler J; Wilkens H; Höper MM; Behr J; Kleber FX; Seeger W
    Ann Intern Med; 2000 Mar; 132(6):435-43. PubMed ID: 10733442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
    Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
    Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.
    Hoeper MM; Schwarze M; Ehlerding S; Adler-Schuermeyer A; Spiekerkoetter E; Niedermeyer J; Hamm M; Fabel H
    N Engl J Med; 2000 Jun; 342(25):1866-70. PubMed ID: 10861321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of pulmonary hypertension with aerosolized iloprost.
    Machherndl S; Kneussl M; Baumgartner H; Schneider B; Petkov V; Schenk P; Lang IM
    Eur Respir J; 2001 Jan; 17(1):8-13. PubMed ID: 11307761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled iloprost for severe pulmonary hypertension.
    Olschewski H; Simonneau G; Galiè N; Higenbottam T; Naeije R; Rubin LJ; Nikkho S; Speich R; Hoeper MM; Behr J; Winkler J; Sitbon O; Popov W; Ghofrani HA; Manes A; Kiely DG; Ewert R; Meyer A; Corris PA; Delcroix M; Gomez-Sanchez M; Siedentop H; Seeger W;
    N Engl J Med; 2002 Aug; 347(5):322-9. PubMed ID: 12151469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases].
    Nikolaeva EV; Yudkina NN; Kurmukov IA; Novikova DS; Markelova EI; Volkov AV
    Ter Arkh; 2015; 87(5):24-32. PubMed ID: 26155616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nebulised iloprost on pulmonary function and gas exchange in severe pulmonary hypertension.
    Reichenberger F; Mainwood A; Doughty N; Fineberg A; Morrell NW; Pepke-Zaba J
    Respir Med; 2007 Feb; 101(2):217-22. PubMed ID: 16831539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe precapillary pulmonary hypertension in possible antiphospholipid syndrome--partially successful long-term therapy with continuous intravenous iloprost administration. A case report with discussion of new treatment methods].
    Halank M; Rubens C; Ewert R; Höffken G; Braun J
    Z Rheumatol; 2000 Oct; 59(5):334-42. PubMed ID: 11142929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.
    Humbert M; Sanchez O; Fartoukh M; Jagot JL; Le Gall C; Sitbon O; Parent F; Simonneau G
    Eur Respir J; 1999 Jun; 13(6):1351-6. PubMed ID: 10445611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled low-dose iloprost for pulmonary hypertension: a prospective, multicenter, open-label study.
    Sun YJ; Xiong CM; Shan GL; Gu Q; Zeng WJ; Lu XL; Zhu F; Liu ZH; Ni XH; He JG;
    Clin Cardiol; 2012 Jun; 35(6):365-70. PubMed ID: 22488211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerosolized iloprost in CREST syndrome related pulmonary hypertension.
    Launay D; Hachulla E; Hatron PY; Goullard L; Onimus T; Robin S; Fauchais AL; Queyrel V; Michon-Pasturel U; Hebbar M; Saulnier F; Devulder B
    J Rheumatol; 2001 Oct; 28(10):2252-6. PubMed ID: 11669165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different hemodynamic responses between acute and chronic infusion of iloprost (prostacyclin-stable analogue) in severe pulmonary hypertension.
    Gomez-Sanchez MA; de la Calzada CS; Gomez Pajuelo C; Tascon JC; Alonso M; Andreu J; Aranzana M; de la Fuente A
    Am Rev Respir Dis; 1991 Dec; 144(6):1404-5. PubMed ID: 1720602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.
    Hoeper MM; Olschewski H; Ghofrani HA; Wilkens H; Winkler J; Borst MM; Niedermeyer J; Fabel H; Seeger W
    J Am Coll Cardiol; 2000 Jan; 35(1):176-82. PubMed ID: 10636277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Iloprost as inhalational and intravenous long-term treatment of patients with primary pulmonary hypertension. Register of the Berlin Study Group for Pulmonary Hypertension]].
    Ewert R; Opitz C; Wensel R; Winkler J; Höffken G; Frank W; Berger F; Kleber FX; Hetzer R
    Z Kardiol; 2000 Nov; 89(11):987-99. PubMed ID: 11149275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of domiciliary intravenous iloprost in idiopathic and connective tissue disease-associated pulmonary arterial hypertension.
    Ramjug S; Hussain N; Hurdman J; Elliot CA; Sabroe I; Armstrong IJ; Billings C; Hamilton N; Kiely DG; Condliffe R
    Respirology; 2017 Feb; 22(2):372-377. PubMed ID: 27651181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost.
    Higenbottam TW; Butt AY; Dinh-Xaun AT; Takao M; Cremona G; Akamine S
    Heart; 1998 Feb; 79(2):175-9. PubMed ID: 9538312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.
    Oudiz RJ; Schilz RJ; Barst RJ; Galié N; Rich S; Rubin LJ; Simonneau G;
    Chest; 2004 Aug; 126(2):420-7. PubMed ID: 15302727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of intermittent Iloprost infusion on pulmonary arterial pressure in connective tissue disease.
    Caravita S; Wu SC; Secchi MB; Dadone V; Bencini C; Pierini S
    Eur J Intern Med; 2011 Oct; 22(5):518-21. PubMed ID: 21925064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.